Applications of nuclear magnetic resonance spectroscopy to antibiotics. I. Specific identification of penicillins and cephalosporins.
D000667:Ampicillin / Q000032:analysis; D002509:Cephaloridine / Q000032:analysis; D002511:Cephalosporins / Q000032:analysis*; D002512:Cephalothin / Q000032:analysis; D003023:Cloxacillin / Q000032:analysis; D003903:Deuterium; D004009:Dicloxacillin / Q000032:analysis; D004121:Dimethyl Sulfoxide; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008712:Methicillin / Q000032:analysis; D008722:Methods; D009254:Nafcillin / Q000032:analysis; D010068:Oxacillin / Q000032:analysis; D010400:Penicillin G / Q000032:analysis; D010401:Penicillin G Benzathine / Q000032:analysis; D010402:Penicillin G Procaine / Q000032:analysis; D010404:Penicillin V / Q000031:analogs & derivatives / Q000032:analysis; D010406:Penicillins / Q000032:analysis*
D002511:Cephalosporins; D010406:Penicillins; D010402:Penicillin G Procaine; D009254:Nafcillin; D000667:Ampicillin; D003903:Deuterium; D004009:Dicloxacillin; D002509:Cephaloridine; D003023:Cloxacillin; D010400:Penicillin G; D008712:Methicillin; D002512:Cephalothin; D010401:Penicillin G Benzathine; D010068:Oxacillin; D004121:Dimethyl Sulfoxide; D010404:Penicillin V